Pricing Log in Create free account
Friday 6 November 2026 Export MED’s income statement to Excel — free account

MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024.

Revenue
−19.4%
EPS
−645.8%
Free cash flow
−73.3%

Quarter to September 2026, against a year earlier

12.81 0.34 −2.59%
Market cap
$142.4M
P/E
0.0×
Fwd P/E
−6.0×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 1.73
Sold, $m 0.23
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — 1 — 1 — — 3 — 1 —
Sell — — — — — — — — — 1 — —
Insider Ownership 6.00%

Capital & Financial Ratios $m

Size
Market Cap 142.35
Revenue ttm 299.57
Net income ttm (40.85)
Free cash flow ttm (0.23)
Net debt Q (172.53)
Valuation
P/E 0.00
Forward P/E (5.99) (negative: loss-making)
Price / sales 0.48
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.79
Financial health
Current ratio Q 4.82 (at or above 1.5: strong)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q 24.69
Growth
Revenue growth Q −19.42% (below 0%: shrinking)
Operating income growth Q −374.34% (below 0%: shrinking)
EPS, this year −43.33% (below 0%: weak)
EPS, next year A +95.35% (at or above 15%: strong)
Revenue, next year A −25.22% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +20.00% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.0×, against a ten-year median of 1.2×; over the ten years it ranged from −0.1× in 2026 to 7.1× in 2018.
P/S against its own 10 years 24.94%
10-year low 10-year high
P/B against its own 10 years 15.99%
10-year low 10-year high
EV/Sales against its own 10 years 4.32%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—
Growth, 2016–24
−100.0%/yr
  1. 1.07 ’16
  2. 1.44 ’17 +35
  3. 2.19 ’18 +52
  4. 3.38 ’19 +54
  5. 4.52 ’20 +34
  6. 5.68 ’21 +26
  7. 6.56 ’22 +15
  8. 4.95 ’23 −25
  9. 0.00 ’24 −100
paid change on the year, %

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 150 162 167 173
Receivables — — — 4
Inventory 55 42 20 21
Other — — — —
224 214 202 202
2023 2024 2025 Q'26
Payables 86 56 38 39
ST’ Debt — — — —
Other — — — —
92 64 43 42

Compound Annual Growth %

10y 5y 3y
Sales 3.53% (16.22%) (37.74%)
Cash Flow (13.54%) (45.69%) (67.20%)
Earnings 0.00% 0.00% 0.00%
Book Value 8.43% 4.81% 8.66%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate −0.40 Actual −0.19

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 −0.76 −0.55 Beat by 0.21
Q1 FY26 −0.55 −0.19 Beat by 0.36
Q2 FY26 −0.67 −0.28 Beat by 0.39
Q3 FY26 −0.40 −0.19 Beat by 0.21
Q4 FY26 −0.17 — Reports 16 February 2027

EPS $

Mar Jun Sep Dec Year
’26 (0.19) (0.28) (1.57) — —
’25 (0.07) 0.22 (0.21) (1.65) (1.70)
’24 0.76 (0.75) 0.10 0.07 0.19
’23 3.67 2.77 2.12 0.55 9.10
’22 3.59 3.42 3.27 2.41 12.73
’21 3.46 3.96 3.56 2.91 13.89
’20 1.56 1.86 2.91 2.36 8.68
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 76 76 72 — —
’25 116 106 89 75 386
’24 175 169 140 119 602
’23 349 296 236 191 1,072
’22 418 453 390 337 1,599
’21 341 394 413 378 1,526
’20 178 220 271 265 935
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 0 2 3 — —
’25 3 (3) 12 (5) 7
’24 7 13 9 (5) 24
’23 64 43 30 11 148
’22 44 44 55 52 195
’21 65 21 16 (7) 95
’20 27 58 41 20 145
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 3 1 3 — —
’25 2 (5) 11 (7) 1
’24 5 11 8 (7) 17
’23 62 41 28 10 141
’22 41 41 54 43 178
’21 61 13 5 (19) 60
’20 26 57 38 18 139
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 275 302 501 714 935 1,526 1,599 1,072 602 386 300 +3.9% 289 275 — (15.6%)
Gross margin, % 74.91 75.54 75.83 75.22 74.65 73.89 71.34 72.37 73.80 71.33 69.21 (3.6) pt
EBT 27 40 71 92 134 216 184 129 4 (6) (29) n/m
EBT margin, % 9.88 13.37 14.08 12.94 14.36 14.16 11.51 12.01 0.63 (1.46) (9.73) (11.3) pt
Net income 18 28 56 78 103 164 144 99 2 (19) (41) n/m
Per share, $
Per share, $ Revenue 23.18 25.29 41.94 60.63 79.42 130.38 142.79 98.50 55.12 35.13 26.79 +4.7%
Earnings 1.51 2.32 4.67 6.62 8.74 14.01 12.82 9.13 0.19 (1.70) (3.69) n/m
Cash flow 2.14 3.63 5.09 7.16 12.34 8.08 17.38 13.57 2.24 0.63 0.00 (12.8%)
Capex (2.43) (0.27) (0.40) (0.85) (0.50) (2.92) (1.49) (0.60) (0.68) (0.51) (0.02) (15.9%)
Free cash flow (0.29) 3.36 4.69 6.30 11.83 5.15 15.89 12.97 1.56 0.11 (0.02) n/m
Book value 8.11 9.11 9.13 8.91 13.36 17.30 13.85 18.51 19.22 18.11 16.12 +9.3%
Shares, m 12 12 12 12 12 12 11 11 11 11 11 (0.8%)
Valuation, ×
Valuation, × P/E 27.82 31.12 26.83 16.55 22.46 14.95 9.00 7.69 97.89 0.00 0.00 25.4
P/S 1.81 2.87 2.98 1.81 2.47 1.61 0.81 0.71 0.32 0.30 0.48 1.6
P/B 5.18 7.96 13.69 12.30 14.70 12.11 8.31 3.79 0.92 0.59 0.79 8.0
EV/Sales 1.53 2.54 2.78 1.70 2.30 1.56 0.78 0.61 0.11 (0.03) 0.03 1.4
EV/FCF (110.33) 58.43 47.85 25.63 19.12 71.15 8.27 5.76 (6.92) 0.45 (0.34) 11.9
Cash, $m
Cash, $m Operating cash flow 25 43 61 84 145 95 195 148 24 7 0 (13.5%)
Capex (29) (3) (5) (10) (6) (34) (17) (6) (7) (6) 0 (16.6%)
Free cash flow (3) 40 56 74 139 60 178 141 17 1 0 n/m
Balance, $m
Balance, $m Working capital 77 88 85 75 123 137 82 132 150 159 160 +8.4%
Net debt (77) (99) (101) (93) (174) (110) (88) (150) (162) (167) (173) +9.0%
Shareholders’ equity 96 109 109 105 157 202 155 201 210 199 180 +8.4%
Returns, %
Returns, % ROA 15.03 20.75 35.38 42.80 43.70 48.64 40.18 31.76 0.70 (7.02) (16.08) (22.0) pt
ROIC 87.58 254.13 534.74 468.15 0.00 145.43 171.49 153.58 3.77 (28.07) (280.77) (115.6) pt
ROE 19.32 27.10 51.26 72.84 78.49 91.20 80.31 55.77 1.02 (9.13) (20.69) (28.5) pt
People
People Employees 422 399 420 550 713 984 874 634 504 380 — (1.2%)
Revenue/emp, $m 0.65 0.76 1.19 1.30 1.31 1.55 1.83 1.69 1.20 1.02 — +5.1%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

MEDIFAST INC vs peers in Personal Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ANDG Andersen Group Inc. $7.5B — — +4.61% (above 0%: growing) n/m +517.12% (above 0%: growing) 20.26% (4.10%) Compare
HRB H&R Block, Inc. $6.7B 9.6× 8.8× +3.05% (above 0%: growing) +4.55% (above 0%: growing) −1.99% (below 0%: shrinking) 51.91% 32.91% Compare
FTDR Frontdoor Inc. $6.6B 23.1× 21.6× +5.99% (above 0%: growing) +16.55% (above 0%: growing) +12.07% (above 0%: growing) 55.27% 0.00% Compare
BFAM Bright Horizons Family Solutions Inc. $2.7B — (loss-making) — (loss-making) +4.82% (above 0%: growing) n/m +40.92% (above 0%: growing) 24.34% (22.24%) Compare
CSV Carriage Services, Inc. $448.0M 9.5× 10.5× −2.42% (below 0%: shrinking) +33.33% (above 0%: growing) +149.08% (above 0%: growing) 31.17% 19.35% Compare
MED MEDIFAST INC $142.4M — (loss-making) — (loss-making) −19.42% (below 0%: shrinking) n/m −73.32% (below 0%: shrinking) 69.45% (26.87%)
RGS Regis Corporation $60.0M 10.2× — (loss-making) −7.84% (below 0%: shrinking) −62.50% (below 0%: shrinking) +11.33% (above 0%: growing) 100.00% 9.76% Compare
CLIK Click Holdings Limited $5.9M — — — — — — — Compare
EJH E-Home Household Service Holdings Limited $4.2M — (loss-making) — — — +1.99% (above 0%: growing) 25.20% 0.00% Compare
Median of peers $1.6B 9.9× 10.5× +3.83% +10.55% +12.07% 31.17% 0.00%

All 13 Personal Services stocks →

Pay and ownership Proxy statement filed 6 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 5.58m 2.73m 6.00
2024 5.61m 983.51k 10.00
2023 7.04m 2.93m 39.00
2022 5.94m (710.73k) 63.00
2021 6.57m 12.94m 109.00

Ownership

Directors and executive officers, together 3.70%
Renaissance Technologies LLC800 Third AvenueNew York, New York 8.10%
BlackRock, Inc. 7.50%
Charles Schwab Investment Management Inc9800 Schwab WayLone Tree, CO 7.00%
Steamboat Capital Partners LLC24 Maple AvenueRye, NY 6.00%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

MEDIFAST INC (MED) Latest News

3 Nov

Impact 3 · · The Motley Fool

28 Oct

Impact 4 · · StockStory
Impact 3 · · StockStory

27 Oct

Impact 4 · · Simply Wall St.
Impact 3 · · StockStory
Impact 3 · · Zacks

26 Oct

Impact 4 · · The Motley Fool transcript
Impact 4 · · Moby
Impact 4 · · MarketBeat
Impact 4 · · StockStory
Impact 4 · · Business Wire
Impact 3 · · Zacks
Impact 3 · · Associated Press

25 Oct

Impact 3 · · StockStory
Impact 3 · · Simply Wall St.

23 Oct

Impact 3 · · Zacks

15 Oct

Impact 4 · · GlobeNewswire

14 Oct

Impact 3 · · StockStory

13 Oct

Impact 3 · · GlobeNewswire

8 Oct

Impact 4 · · GlobeNewswire

6 Oct

Impact 3 · · Zacks
Impact 3 · · GlobeNewswire

1 Oct

Impact 4 · · GlobeNewswire

29 Sep

Impact 3 · · Zacks
Impact 3 · · GlobeNewswire

9 Sep

Impact 3 ·

4 Sep

Impact 4 ·

2 Sep

Impact 3 ·

27 Aug

Impact 3 ·

21 Aug

Impact 3 ·
stockrow.com/MED · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com